Two agreements on the sale of vaccines to Norway have been completed. According to newspaper VG, that means that Norway will receive at least 500,000 doses of the Pfizer vaccine in the first quarter of 2021.
In total, Norway can buy 2.5 million vaccine doses, which is one percent of what the EU has agreed to buy so far.
“The total volume is 2.5 million doses. It is always a bit uncertain when it comes to the delivery, but at least 500,000 doses will come in the first quarter from Pfizer,” Sweden’s vaccine coordinator Richard Bergström told VG.
He is negotiating vaccine purchase agreements for the EU and is the one who will secure vaccines for Norway by Sweden purchasing Norway’s doses and reselling them to Norway.
To date, two such resale agreements have been completed.
Last week, the Pfizer agreement was completed, and in October, the agreement for Oxford / AstraZeneca’s vaccine candidate was finalized.
© NTB Scanpix / #Norway Today